UK markets closed

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.96-0.64 (-2.50%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close25.60
Bid25.01 x 1400
Ask25.35 x 1800
Day's range24.44 - 25.66
52-week range15.88 - 54.21
Avg. volume1,644,881
Market cap3.87B
Beta (5Y monthly)0.85
PE ratio (TTM)N/A
EPS (TTM)-1.91
Earnings date03 Nov 2021 - 08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est40.31
  • Motley Fool

    Why Iovance Is Up Nearly 11% Today

    Shares of biopharma company Iovance (NASDAQ: IOVA) are poised to end Wednesday's trading session almost 11% higher than Tuesday's close, following an encouraging observation from investment analytics outfit Truist. Namely, the odds of an approval of one of its drug prospects seemingly improved after a rival drug developer was granted permission to expand its trials of a similar therapy. On Monday, Instil Bio (NASDAQ: TIL) announced the Food and Drug Administration had cleared the company's request to widen the scope of its current phase 2 trial of ITIL-168.

  • Zacks

    Implied Volatility Surging for Iovance (IOVA) Stock Options

    Investors need to pay close attention to Iovance (IOVA) stock based on the movements in the options market lately.

  • Zacks

    Iovance (IOVA) Q2 Earnings Miss Estimates, Pipeline in Focus

    Iovance's (IOVA) second-quarter loss is wider than expected. The company is progressing well in terms of development of its pipeline candidates.